According to Acumen Research and Consulting, the global nephrostomy devices market size is expected to reach around US$ 1.5 billion by 2026 and growing at noteworthy CAGR around 7.6 % from period 2019 to 2026.
The main choice to drain a blocked urine recovery system is nephrostomy catheter. Hydronephrosis is the prevalent signal that nephrostomy catheters are used for blocking one or both urers. Nephrostomy catheter is usually placed under local anesthesia, which functions through temporary urine reversal from the blocking site. If correctly trained and skilled resources are used, nephrostomy has a success rate of over 95 per cent. In cases where antibiotics cannot get to the kidney because of blockage, nephrostomy is also helpful. In such instances percutaneous nephrostomy is an excellent alternative therapy because it enables urine to flow into obstructed areas and also enables antibiotics to be instilled at the site of infection. In general, interventional radiologists perform nephrostomy catheter positioning under radiology room or operating room imaging instructions. Cancer of reproductive organs such as ovarian cancer, colon cancer, etc. is the most prevalent cause of nephrosomy. The recent alternative to problems for percutaneous dilation is the dilation catheter. Pertaneous nephrostomy is advisable for chosen patients who develop the symptoms of urolithiasis during pregnancies, although it has been contraindicated in pregnant females. Increased internet penetration and use has resulted to higher internet product purchases. The sale of nephrostomy devices via internet channels rises substantially as goods are easily available online. As a consequence of this, suppliers are providing different kind of nephrostomy appliances to satisfy the increasing demand from ASCs, hospitals and other end-users through e-commerce locations such as IndiaMart, Alibaba and e-bay. In the forecast period, the increasing importance of promotion products via e-commerce locations further stimulates market growth.
The report provides analysis of global Nephrostomy Devices market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
The market drives a number of variables such as enhanced instances of kidney stone disease, an enhanced demand for minimally invasive procedure, and enhanced consumer awareness. Urolithiasis impacts some 12% of the world population, according to a research released in the National Center for Biotechnology Information (NCBI). Moreover, approximately 13% of males and 7% of females grow the renal stone throughout their lives. Nephrostomy aid in restoring urine flow through the blocked ureters to the ordinary functioning of the kidney.
The growing popularity of least invasive processes drives the market as well. In addition, the growth of the market is expected to contribute to increasing lifestyle illnesses. The worldwide market is also influenced by improved healthcare infrastructure in the emerging economies.
Nephrostomy catheters are widely used to drain a blocked urine system. Hydronephroses, which are operated by nephrostomy catheters, are caused by this obstruction. Therefore, an increase in hydronephrosis should boost catheter demand, thereby stimulating development on the market for nephrostomy appliances. Another beneficial effect for the product demand over the forecast years is projected to be increased instances of bladder, ovarian or prostate cancers. In addition, increasing incidence of post-operative diseases is another important driver in patients with renal transplantation.
Due to the less invasive nature of the item, the Guidewire segment is anticipated to have a maximum market share over the forecast era. The rise in the population of older people and the incidence of urinary and bladder illnesses is anticipated to boost product demand and thus influence segment development. Guidewire companies focus on working with health care providers, in order to improve their client base and enhance their industry presence. Thus, such initiatives are anticipated to improve the need for guidelines from producers and the presence of highly qualified professionals in the developed economies. Progress of nephrostomy technology is expected to bring lucratif possibilities to the market, such as introducing the balloon dilation catheter with initial multilayer technology.
End Use Stance
Ambulatory Operating Centres (ASC), which give more personalized facilities, will probably be the fastest CAGR from 2019 to 2026. In addition, the segment is driven by better outcomes in comparison to hospitals and other health facilities.
The risk of infections in ASCs is only half that of hospitals during surgery, which also helps to increase the growth segment. Furthermore, ASCs guarantee that patients receive personalized service through enhanced patient experience, as the task is not to treat distinct kinds of diseases and disorders. However, because of the access of qualified doctors to hospitals and the increased consumer spending power, the hospital sector accounts for a significant market share. It is also anticipated that the segment will be driven by enhancing health infrastructure in development countries and increasing acceptance by physicians of innovative products.
The biggest share in the past was North America. The development is anticipated in the future owing to the favourable reimbursement policies, greater consumer awareness, extremely qualified doctors and the existence of well-established medical services in the region. The latter are anticipated to grow. Furthermore, rapid adoption of high-tech medical products is anticipated to boost the region's market. Increased public financing for R&D operations in operating instruments and processes also has a positive impact on regional market development.
Increasing instances of kidney disorder, favorable public initiatives and different programs by NGOs are anticipated to increase consumer consciousness in the Asia-Pacific region from 2019-2026, the largest CAGR. In addition, the existence in China and India of a big amount of important businesses contributes to the development of the industry. In the emerging economies of the Asian Pacific, the rapidly growing medical tourism industry is anticipated to further increase product demand and thus increase market growth.
Global Nephrostomy Devices Market, By Product
Global Nephrostomy Devices Market, By End Use
Global Nephrostomy Devices Market, By Geography
The market research study on “Nephrostomy Devices Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Nephrostomy Devices market segments with market dynamics and their impact. The report also covers basic technology development policies.
This study offers an assessment of the recent trends in the sector in each sub-segment from 2015 to 2026 and predicts income development at worldwide, regional and nation levels, respectively. ARC segmented the worldwide market report on nephrostomy machines according to product, end use and region for the purpose of this research:
Key Players & Strategies
Cardinal Health; Teleflex, Inc.; Argon Medical; Boston Scientific Corp.; Becton, Dickinson and Company; Cook Medical; Coloplast Group; B. Braun Melsungen AG; Olympus Corp.; and Uresil LLC are major firms in the market, with a greater focus on the new product development, technological progress and M&A, to enhance their position on the worldwide market. Cook Medical, for example, started Universa together with two percutaneous urinary drainage sets in February 2017. The brand involves foley and ureteral catheters in various configurations and sizes to satisfy doctors and patients ' particular reference and needs.
Acumen Research and Consulting predict that, the nephrostomy devices market value is anticipated to be worth around US$ 1.5 billion in 2026.
The nephrostomy devices market is anticipated to grow over 7.6% CAGR during the forecast period 2019 to 2026.
Ambulatory Operating Centres (ASC), which give more personalized facilities, will probably be the fastest CAGR from 2019 to 2026.
North America held maximum share in 2018 for nephrostomy devices market.
Asia Pacific is projected to grow at a fast pace during forecast period in the nephrostomy devices market.
Due to the less invasive nature of the item, the Guidewire segment is anticipated to have a maximum market share over the forecast era.
Cardinal Health; Teleflex, Inc.; Argon Medical; Boston Scientific Corp.; Becton, Dickinson and Company; Cook Medical; Coloplast Group; B. Braun Melsungen AG; Olympus Corp.; and Uresil LLC are major firms in the nephrostomy devices market.